Low AUC after reference product [Study As­sess­ment]

posted by mittyri – Russia, 2018-03-15 11:56 (2257 d 00:26 ago) – Posting: # 18550
Views: 5,051

Hi Helmut,

❝ Correct – if you didn’t state such a possible reason for exclusion it in the protocol.

If 5% GMR for ref is not mentioned in the Protocol isn't possible just to refer to EMA or other appropriate GL (depending on the jurisdiction)?

Have you ever seen lucky guys in EMA jurisdiction who stated in the protocol some additional reasons for exclusion (not mentioned in GL) after ending the bioanalytical part and successfully applied them in borderline case like that?

Kind regards,

Complete thread:

UA Flag
 Admin contact
23,029 posts in 4,834 threads, 1,644 registered users;
27 visitors (0 registered, 27 guests [including 5 identified bots]).
Forum time: 13:23 CEST (Europe/Vienna)

We must be careful not to confuse data with the abstractions
we use to analyze them.    William James

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz